Craig Bijou
Stock Analyst at B of A Securities
(4.77)
# 138
Out of 4,918 analysts
63
Total ratings
62.86%
Success rate
57.97%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Underperform | $18 → $9 | $7.78 | +15.68% | 2 | Jul 9, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $48.51 | +73.16% | 4 | Apr 25, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $119.50 | +17.15% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $13.63 | +24.72% | 3 | Feb 20, 2025 | |
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $52.63 | +84.31% | 4 | Jan 9, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $13.14 | +36.99% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $108.51 | +33.63% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $84.86 | +21.38% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $74.04 | +14.80% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $71.32 | +20.58% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $70.69 | +34.39% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $17.05 | +111.14% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $6.65 | +576.69% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $3.48 | +3,348.28% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $6.89 | +335.41% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $11.68 | +11.30% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $11.04 | +280.43% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $481.09 | -52.19% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $392.73 | -41.44% | 4 | Jul 26, 2019 |
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $7.78
Upside: +15.68%
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $48.51
Upside: +73.16%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $119.50
Upside: +17.15%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $13.63
Upside: +24.72%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $52.63
Upside: +84.31%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $13.14
Upside: +36.99%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $108.51
Upside: +33.63%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $84.86
Upside: +21.38%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $74.04
Upside: +14.80%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $71.32
Upside: +20.58%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $70.69
Upside: +34.39%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $17.05
Upside: +111.14%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $6.65
Upside: +576.69%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $3.48
Upside: +3,348.28%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $6.89
Upside: +335.41%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $11.68
Upside: +11.30%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $11.04
Upside: +280.43%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $481.09
Upside: -52.19%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $392.73
Upside: -41.44%